Fluocinolone Acetonide + Neomycin + Phenylephrine + Polymyxin B

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Fluocinolone Acetonide fluocinolone-acetonide
Neomycin neomycin
Phenylephrine phenylephrine
Polymyxin B polymyxin-b

Brands with this exact combination

Brand	Composition & strength	Manufacturer
SynalarCA ES US	nasal Fluocinolone Acetonide 0.1 mg + Neomycin + Phenylephrine + Polymyxin B nasal Fluocinolone Acetonide 1.25 mg/1 mL + Neomycin + Phenylephrine + Polymyxin B topical ×4 Fluocinolone Acetonide 0.25 mg topical ×2 Fluocinolone Acetonide 0.025 % Other 2 compositions	Tora Laboratories S.L.U.
fluocinolona + fenilefrina + neomicina + polimixina BES	0.1 mg / 1.25 mg/1 mL	Tora Laboratories S.L.U.

Brand

Composition & strength

Manufacturer

SynalarCA ES US

nasal Fluocinolone Acetonide 0.1 mg + Neomycin + Phenylephrine + Polymyxin B
nasal Fluocinolone Acetonide 1.25 mg/1 mL + Neomycin + Phenylephrine + Polymyxin B
topical ×4 Fluocinolone Acetonide 0.25 mg
topical ×2 Fluocinolone Acetonide 0.025 %

Other 2 compositions

Tora Laboratories S.L.U.

fluocinolona + fenilefrina + neomicina + polimixina BES

0.1 mg / 1.25 mg/1 mL

Tora Laboratories S.L.U.

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.